RIL
JANX icon

Rothschild Investment LLC’s Janux Therapeutics JANX Stock Holding History

Rothschild Investment LLC’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.14K Buy
+82
New +$1.12K ﹤0.01% 2813
2025
Q4 		– Sell
-50
Closed -$1.22K – 3466
2025
Q3 		$1.22K Sell
50
-45
-47% -$1.1K ﹤0.01% 2503
2025
Q2 		$2.19K Buy
95
+50
+111% +$1.32K ﹤0.01% 2012
2025
Q1 		$1.22K Buy
45
+5
+13% +$188 ﹤0.01% 2224
2024
Q4 		$2.14K Buy
40
+5
+14% +$264 ﹤0.01% 1757
2024
Q3 		$1.59K Buy
35
+25
+250% +$1.09K ﹤0.01% 1851
2024
Q2 		$419 Buy
+10
New +$470 ﹤0.01% 2129

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Rothschild Investment LLC's JANX Position: Q1 2026 in Review

Rothschild Investment LLC opened a new position in Janux Therapeutics (JANX) in Q1 2026: 82 shares worth $1.14K. The stake represents ﹤0.01% of the portfolio and ranks #2813 among its holdings. This is a return to the name: Rothschild Investment LLC previously reported a position in JANX as recently as Q3 2025.

Rothschild Investment LLC first reported a position in JANX in Q2 2024 and has held it in 7 quarters since. The position peaked at $2.19K in Q2 2025. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

  • Rothschild Investment LLC held 82 shares of Janux Therapeutics worth $1.14K as of Q1 2026.
  • Janux Therapeutics was a new Rothschild Investment LLC position in Q1 2026.
  • Janux Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #2813 holding.
  • Rothschild Investment LLC first reported a position in Janux Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • Rothschild Investment LLC's Janux Therapeutics position peaked at $2.19K in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.